Jacques Beltrand

4.4k total citations
81 papers, 2.1k citations indexed

About

Jacques Beltrand is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Jacques Beltrand has authored 81 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Endocrinology, Diabetes and Metabolism, 28 papers in Genetics and 24 papers in Surgery. Recurrent topics in Jacques Beltrand's work include Diabetes Management and Research (29 papers), Diabetes and associated disorders (22 papers) and Pancreatic function and diabetes (21 papers). Jacques Beltrand is often cited by papers focused on Diabetes Management and Research (29 papers), Diabetes and associated disorders (22 papers) and Pancreatic function and diabetes (21 papers). Jacques Beltrand collaborates with scholars based in France, Switzerland and United States. Jacques Beltrand's co-authors include Michel Polak, Claire Lévy‐Marchal, Olivier Claris, Kristin L. Connor, Mark H. Vickers, D. M. Sloboda, Kanetee Busiah, Michael J. Meaney, Rasa Verkauskienė and Jean‐Jacques Robert and has published in prestigious journals such as Nature Immunology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jacques Beltrand

77 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Beltrand France 25 867 566 544 503 355 81 2.1k
R. Coutant France 32 1.1k 1.3× 681 1.2× 491 0.9× 812 1.6× 677 1.9× 119 2.3k
Giorgio Radetti Italy 28 1.3k 1.5× 246 0.4× 314 0.6× 616 1.2× 525 1.5× 90 2.4k
Lars Hagenäs Sweden 29 672 0.8× 390 0.7× 450 0.8× 918 1.8× 680 1.9× 87 2.2k
M Garabédian France 31 589 0.7× 266 0.5× 370 0.7× 543 1.1× 482 1.4× 109 3.4k
Merih Berberoğlu Türkiye 22 717 0.8× 347 0.6× 211 0.4× 579 1.2× 726 2.0× 173 2.0k
Karl Otfried Schwab Germany 26 757 0.9× 289 0.5× 246 0.5× 542 1.1× 561 1.6× 85 1.9k
Isabelle Fajardy France 20 184 0.2× 259 0.5× 386 0.7× 320 0.6× 301 0.8× 44 1.5k
Zehra Aycan Türkiye 24 886 1.0× 312 0.6× 223 0.4× 559 1.1× 687 1.9× 220 2.2k
Tove Lekva Norway 25 470 0.5× 305 0.5× 325 0.6× 96 0.2× 476 1.3× 78 1.8k
Helmuth G. Dörr Germany 27 1.1k 1.3× 229 0.4× 543 1.0× 489 1.0× 1.1k 3.2× 141 2.4k

Countries citing papers authored by Jacques Beltrand

Since Specialization
Citations

This map shows the geographic impact of Jacques Beltrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Beltrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Beltrand more than expected).

Fields of papers citing papers by Jacques Beltrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Beltrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Beltrand. The network helps show where Jacques Beltrand may publish in the future.

Co-authorship network of co-authors of Jacques Beltrand

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Beltrand. A scholar is included among the top collaborators of Jacques Beltrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Beltrand. Jacques Beltrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Polak, Michel, Alfonso Galderisi, Kanetee Busiah, et al.. (2024). Diabète « néonatal » : une maladie neuro-endocrine, au-delà de la cellule à insuline. De la maladie rare à la maladie fréquente. Bulletin de l Académie Nationale de Médecine. 209(1). 87–97.
2.
Stoupa, Athanasia, Mônica M. França, Haruki Fujisawa, et al.. (2024). Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiency. Genetics in Medicine. 26(12). 101280–101280. 3 indexed citations
3.
4.
Baron, S., Jacques Beltrand, Sophie Borot, et al.. (2024). Transition from Paediatric to Adult Diabetes Care in People with Type 1 Diabetes: An Online Survey from France. Diabetes Therapy. 15(10). 2211–2222.
5.
Weiss, Laurence, Philippe Reix, Helen Mosnier-Pudar, et al.. (2023). Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis. Diabetes & Metabolism. 49(3). 101444–101444. 8 indexed citations
6.
Galderisi, Alfonso, Dulanjalee Kariyawasam, Athanasia Stoupa, et al.. (2023). Glucose pattern in children with classical congenital adrenal hyperplasia: evidence from continuous glucose monitoring. European Journal of Endocrinology. 189(5). K19–K24. 1 indexed citations
7.
Kariyawasam, Dulanjalee, Kristina Casteels, Nathalie Garrec, et al.. (2022). Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial. The Lancet Digital Health. 4(3). e158–e168. 37 indexed citations
8.
Tréluyer, Jean‐Marc, et al.. (2021). Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial. PLoS ONE. 16(3). e0248549–e0248549. 6 indexed citations
9.
Stoupa, Athanasia, Isabelle Flechtner, Graziella Pinto, et al.. (2018). Clinical and Preliminary Molecular Description of a Cohort of Patients with Growth Retardation due to Severe Primary IGF1 Deficiency (GROWPATI Study). HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
10.
Rouxel, Ophélie, Jennifer Da Silva, Lucie Beaudoin, et al.. (2017). Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nature Immunology. 18(12). 1321–1331. 184 indexed citations
11.
Stoupa, Athanasia, Dinane Samara‐Boustani, Isabelle Flechtner, et al.. (2017). Efficacy and Safety of Continuous Subcutaneous Infusion of Recombinant Human Gonadotropins for Congenital Micropenis during Early Infancy. Hormone Research in Paediatrics. 87(2). 103–110. 34 indexed citations
12.
Beltrand, Jacques, Kanetee Busiah, Zoubir Djerada, et al.. (2016). Glibentek, a New Suspension of Glibenclamide for Patients with Neonatal Diabetes, is as Effective and more Convenient than Crushed Tablets. 86. 1 indexed citations
13.
Bouazza, Naïm, Zoubir Djerada, Claire Gozalo, et al.. (2016). Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. European Journal of Clinical Pharmacology. 72(11). 1373–1379. 3 indexed citations
14.
Besançon, Alix, et al.. (2014). Management of neonates born to women with Graves' disease: a cohort study. European Journal of Endocrinology. 170(6). 855–862. 57 indexed citations
15.
Beltrand, Jacques & Jean‐Jacques Robert. (2013). L’insulinothérapie en pédiatrie. Archives de Pédiatrie. 20. S131–S135. 2 indexed citations
16.
Kratzer, Roland, Jean‐Baptiste Arnoux, Yamina Hamel, et al.. (2012). ZnT8 Is a Major CD8+ T Cell–Recognized Autoantigen in Pediatric Type 1 Diabetes. Diabetes. 61(7). 1779–1784. 46 indexed citations
17.
Samara‐Boustani, Dinane, Caroline Elie, M. Dabbas, et al.. (2011). High prevalence of hirsutism and menstrual disorders in obese adolescent girls and adolescent girls with type 1 diabetes mellitus despite different hormonal profiles. European Journal of Endocrinology. 166(2). 307–316. 30 indexed citations
18.
Beltrand, Jacques, Najiba Lahlou, Tifenn Le Charpentier, et al.. (2010). Resistance to leptin-replacement therapy in Berardinelli–Seip congenital lipodystrophy: an immunological origin. European Journal of Endocrinology. 162(6). 1083–1091. 46 indexed citations
19.
Beltrand, Jacques, Florentia Kaguelidou, Rasa Verkauskienė, et al.. (2009). Catch-Up Growth Following Fetal Growth Restriction Promotes Rapid Restoration of Fat Mass but Without Metabolic Consequences at One Year of Age. PLoS ONE. 4(4). e5343–e5343. 53 indexed citations
20.
Beltrand, Jacques & Claire Lévy‐Marchal. (2008). Pathophysiology of insulin resistance in subjects born small for gestational age. Best Practice & Research Clinical Endocrinology & Metabolism. 22(3). 503–515. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Coutant Breakdown of academic impact, for papers by Giorgio Radetti Breakdown of academic impact, for papers by Lars Hagenäs Breakdown of academic impact, for papers by M Garabédian Breakdown of academic impact, for papers by Merih Berberoğlu Breakdown of academic impact, for papers by Karl Otfried Schwab Breakdown of academic impact, for papers by Isabelle Fajardy Breakdown of academic impact, for papers by Zehra Aycan Breakdown of academic impact, for papers by Tove Lekva Breakdown of academic impact, for papers by Helmuth G. Dörr
Rankless by CCL
2026